nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—type 2 diabetes mellitus	0.489	1	CbGaD
Risedronate—PTGS2—leg—type 2 diabetes mellitus	0.00556	0.126	CbGeAlD
Risedronate—PTGS2—hindlimb—type 2 diabetes mellitus	0.00497	0.113	CbGeAlD
Risedronate—FDPS—islet of Langerhans—type 2 diabetes mellitus	0.00382	0.0865	CbGeAlD
Risedronate—FDPS—nephron tubule—type 2 diabetes mellitus	0.00307	0.0697	CbGeAlD
Risedronate—PTGS2—artery—type 2 diabetes mellitus	0.00305	0.069	CbGeAlD
Risedronate—FDPS—cardiovascular system—type 2 diabetes mellitus	0.00276	0.0626	CbGeAlD
Risedronate—FDPS—kidney—type 2 diabetes mellitus	0.0027	0.0612	CbGeAlD
Risedronate—FDPS—pancreas—type 2 diabetes mellitus	0.00268	0.0608	CbGeAlD
Risedronate—FDPS—cortex of kidney—type 2 diabetes mellitus	0.00263	0.0596	CbGeAlD
Risedronate—PTGS2—endothelium—type 2 diabetes mellitus	0.00257	0.0583	CbGeAlD
Risedronate—FDPS—adipose tissue—type 2 diabetes mellitus	0.00243	0.0552	CbGeAlD
Risedronate—FDPS—liver—type 2 diabetes mellitus	0.00171	0.0387	CbGeAlD
Risedronate—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.00146	0.0332	CbGeAlD
Risedronate—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.00106	0.024	CbGeAlD
Risedronate—PTGS2—kidney—type 2 diabetes mellitus	0.00104	0.0235	CbGeAlD
Risedronate—PTGS2—pancreas—type 2 diabetes mellitus	0.00103	0.0233	CbGeAlD
Risedronate—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000933	0.0211	CbGeAlD
Risedronate—PTGS2—liver—type 2 diabetes mellitus	0.000654	0.0148	CbGeAlD
Risedronate—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000207	0.000606	CcSEcCtD
Risedronate—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000206	0.000604	CcSEcCtD
Risedronate—Flatulence—Losartan—type 2 diabetes mellitus	0.000206	0.000603	CcSEcCtD
Risedronate—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000206	0.000601	CcSEcCtD
Risedronate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000205	0.0006	CcSEcCtD
Risedronate—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000205	0.0006	CcSEcCtD
Risedronate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000205	0.000599	CcSEcCtD
Risedronate—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000205	0.000599	CcSEcCtD
Risedronate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000205	0.000599	CcSEcCtD
Risedronate—Hypertension—Metformin—type 2 diabetes mellitus	0.000203	0.000595	CcSEcCtD
Risedronate—Urticaria—Glyburide—type 2 diabetes mellitus	0.000203	0.000595	CcSEcCtD
Risedronate—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000203	0.000594	CcSEcCtD
Risedronate—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000203	0.000594	CcSEcCtD
Risedronate—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000203	0.000593	CcSEcCtD
Risedronate—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000203	0.000593	CcSEcCtD
Risedronate—Back pain—Losartan—type 2 diabetes mellitus	0.000202	0.000592	CcSEcCtD
Risedronate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000202	0.000592	CcSEcCtD
Risedronate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000202	0.000592	CcSEcCtD
Risedronate—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000201	0.000589	CcSEcCtD
Risedronate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000201	0.000588	CcSEcCtD
Risedronate—Myalgia—Metformin—type 2 diabetes mellitus	0.000201	0.000587	CcSEcCtD
Risedronate—Chest pain—Metformin—type 2 diabetes mellitus	0.000201	0.000587	CcSEcCtD
Risedronate—Vertigo—Irbesartan—type 2 diabetes mellitus	0.0002	0.000584	CcSEcCtD
Risedronate—Headache—Pioglitazone—type 2 diabetes mellitus	0.0002	0.000584	CcSEcCtD
Risedronate—Syncope—Irbesartan—type 2 diabetes mellitus	0.000199	0.000583	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000199	0.000583	CcSEcCtD
Risedronate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000198	0.00058	CcSEcCtD
Risedronate—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000198	0.00058	CcSEcCtD
Risedronate—Nausea—Glipizide—type 2 diabetes mellitus	0.000198	0.000578	CcSEcCtD
Risedronate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000197	0.000577	CcSEcCtD
Risedronate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000197	0.000575	CcSEcCtD
Risedronate—Pain—Gliclazide—type 2 diabetes mellitus	0.000197	0.000575	CcSEcCtD
Risedronate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000197	0.000575	CcSEcCtD
Risedronate—Rash—Glimepiride—type 2 diabetes mellitus	0.000196	0.000572	CcSEcCtD
Risedronate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000196	0.000572	CcSEcCtD
Risedronate—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000195	0.000572	CcSEcCtD
Risedronate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000195	0.000571	CcSEcCtD
Risedronate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000195	0.00057	CcSEcCtD
Risedronate—Headache—Glimepiride—type 2 diabetes mellitus	0.000194	0.000569	CcSEcCtD
Risedronate—Cough—Irbesartan—type 2 diabetes mellitus	0.000194	0.000568	CcSEcCtD
Risedronate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000194	0.000567	CcSEcCtD
Risedronate—Anaemia—Losartan—type 2 diabetes mellitus	0.000193	0.000566	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000192	0.000563	CcSEcCtD
Risedronate—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000192	0.000562	CcSEcCtD
Risedronate—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000192	0.000562	CcSEcCtD
Risedronate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00056	CcSEcCtD
Risedronate—Angioedema—Losartan—type 2 diabetes mellitus	0.000191	0.000559	CcSEcCtD
Risedronate—Infection—Metformin—type 2 diabetes mellitus	0.000191	0.000559	CcSEcCtD
Risedronate—Insomnia—Valsartan—type 2 diabetes mellitus	0.000191	0.000559	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00019	0.000556	CcSEcCtD
Risedronate—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00019	0.000555	CcSEcCtD
Risedronate—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000189	0.000554	CcSEcCtD
Risedronate—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000189	0.000554	CcSEcCtD
Risedronate—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000189	0.000554	CcSEcCtD
Risedronate—Shock—Metformin—type 2 diabetes mellitus	0.000189	0.000553	CcSEcCtD
Risedronate—Insomnia—Orlistat—type 2 diabetes mellitus	0.000189	0.000552	CcSEcCtD
Risedronate—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000189	0.000552	CcSEcCtD
Risedronate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000189	0.000552	CcSEcCtD
Risedronate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000189	0.000552	CcSEcCtD
Risedronate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000188	0.000551	CcSEcCtD
Risedronate—Vertigo—Losartan—type 2 diabetes mellitus	0.000188	0.00055	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000188	0.00055	CcSEcCtD
Risedronate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000188	0.00055	CcSEcCtD
Risedronate—Syncope—Losartan—type 2 diabetes mellitus	0.000188	0.000549	CcSEcCtD
Risedronate—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000187	0.000548	CcSEcCtD
Risedronate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000187	0.000546	CcSEcCtD
Risedronate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000186	0.000545	CcSEcCtD
Risedronate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000186	0.000544	CcSEcCtD
Risedronate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000186	0.000543	CcSEcCtD
Risedronate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000185	0.000542	CcSEcCtD
Risedronate—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000185	0.000542	CcSEcCtD
Risedronate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000184	0.000539	CcSEcCtD
Risedronate—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000184	0.000539	CcSEcCtD
Risedronate—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000184	0.000538	CcSEcCtD
Risedronate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000184	0.000538	CcSEcCtD
Risedronate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000184	0.000537	CcSEcCtD
Risedronate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000184	0.000537	CcSEcCtD
Risedronate—Cough—Losartan—type 2 diabetes mellitus	0.000183	0.000534	CcSEcCtD
Risedronate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000183	0.000534	CcSEcCtD
Risedronate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000182	0.000533	CcSEcCtD
Risedronate—Fatigue—Valsartan—type 2 diabetes mellitus	0.000182	0.000533	CcSEcCtD
Risedronate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000182	0.000532	CcSEcCtD
Risedronate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000182	0.000532	CcSEcCtD
Risedronate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000181	0.00053	CcSEcCtD
Risedronate—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000181	0.000528	CcSEcCtD
Risedronate—Constipation—Valsartan—type 2 diabetes mellitus	0.000181	0.000528	CcSEcCtD
Risedronate—Infection—Irbesartan—type 2 diabetes mellitus	0.00018	0.000527	CcSEcCtD
Risedronate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00018	0.000527	CcSEcCtD
Risedronate—Fatigue—Orlistat—type 2 diabetes mellitus	0.00018	0.000526	CcSEcCtD
Risedronate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000179	0.000525	CcSEcCtD
Risedronate—Shock—Irbesartan—type 2 diabetes mellitus	0.000179	0.000522	CcSEcCtD
Risedronate—Pain—Orlistat—type 2 diabetes mellitus	0.000178	0.000522	CcSEcCtD
Risedronate—Arthralgia—Losartan—type 2 diabetes mellitus	0.000178	0.000521	CcSEcCtD
Risedronate—Myalgia—Losartan—type 2 diabetes mellitus	0.000178	0.000521	CcSEcCtD
Risedronate—Chest pain—Losartan—type 2 diabetes mellitus	0.000178	0.000521	CcSEcCtD
Risedronate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000178	0.000521	CcSEcCtD
Risedronate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000178	0.000521	CcSEcCtD
Risedronate—Anxiety—Losartan—type 2 diabetes mellitus	0.000178	0.000519	CcSEcCtD
Risedronate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000177	0.000516	CcSEcCtD
Risedronate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000176	0.000516	CcSEcCtD
Risedronate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000176	0.000516	CcSEcCtD
Risedronate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000175	0.000513	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000175	0.000513	CcSEcCtD
Risedronate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000175	0.000512	CcSEcCtD
Risedronate—Dry mouth—Losartan—type 2 diabetes mellitus	0.000174	0.00051	CcSEcCtD
Risedronate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000173	0.000505	CcSEcCtD
Risedronate—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000173	0.000505	CcSEcCtD
Risedronate—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000173	0.000505	CcSEcCtD
Risedronate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000171	0.000502	CcSEcCtD
Risedronate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000171	0.000499	CcSEcCtD
Risedronate—Infection—Losartan—type 2 diabetes mellitus	0.00017	0.000496	CcSEcCtD
Risedronate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000169	0.000495	CcSEcCtD
Risedronate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000169	0.000495	CcSEcCtD
Risedronate—Shock—Losartan—type 2 diabetes mellitus	0.000168	0.000492	CcSEcCtD
Risedronate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000168	0.000491	CcSEcCtD
Risedronate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000167	0.00049	CcSEcCtD
Risedronate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000167	0.000488	CcSEcCtD
Risedronate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000166	0.000487	CcSEcCtD
Risedronate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000166	0.000486	CcSEcCtD
Risedronate—Fatigue—Metformin—type 2 diabetes mellitus	0.000166	0.000485	CcSEcCtD
Risedronate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000166	0.000485	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000165	0.000484	CcSEcCtD
Risedronate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000165	0.000483	CcSEcCtD
Risedronate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000165	0.000483	CcSEcCtD
Risedronate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000165	0.000482	CcSEcCtD
Risedronate—Constipation—Metformin—type 2 diabetes mellitus	0.000164	0.000481	CcSEcCtD
Risedronate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000164	0.00048	CcSEcCtD
Risedronate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000163	0.000477	CcSEcCtD
Risedronate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000163	0.000476	CcSEcCtD
Risedronate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000163	0.000476	CcSEcCtD
Risedronate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000162	0.000473	CcSEcCtD
Risedronate—Rash—Glyburide—type 2 diabetes mellitus	0.000161	0.000472	CcSEcCtD
Risedronate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000161	0.000472	CcSEcCtD
Risedronate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000161	0.000472	CcSEcCtD
Risedronate—Syncope—Ramipril—type 2 diabetes mellitus	0.000161	0.000471	CcSEcCtD
Risedronate—Headache—Glyburide—type 2 diabetes mellitus	0.00016	0.000469	CcSEcCtD
Risedronate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00016	0.000467	CcSEcCtD
Risedronate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000158	0.000461	CcSEcCtD
Risedronate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000157	0.00046	CcSEcCtD
Risedronate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000157	0.00046	CcSEcCtD
Risedronate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000157	0.000458	CcSEcCtD
Risedronate—Cough—Ramipril—type 2 diabetes mellitus	0.000157	0.000458	CcSEcCtD
Risedronate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000156	0.000458	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000156	0.000455	CcSEcCtD
Risedronate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000156	0.000455	CcSEcCtD
Risedronate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000155	0.000454	CcSEcCtD
Risedronate—Pain—Irbesartan—type 2 diabetes mellitus	0.000155	0.000454	CcSEcCtD
Risedronate—Insomnia—Losartan—type 2 diabetes mellitus	0.000154	0.000452	CcSEcCtD
Risedronate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000154	0.00045	CcSEcCtD
Risedronate—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000153	0.000449	CcSEcCtD
Risedronate—Urticaria—Metformin—type 2 diabetes mellitus	0.000153	0.000447	CcSEcCtD
Risedronate—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000153	0.000447	CcSEcCtD
Risedronate—Myalgia—Ramipril—type 2 diabetes mellitus	0.000153	0.000447	CcSEcCtD
Risedronate—Chest pain—Ramipril—type 2 diabetes mellitus	0.000153	0.000447	CcSEcCtD
Risedronate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000152	0.000445	CcSEcCtD
Risedronate—Anxiety—Ramipril—type 2 diabetes mellitus	0.000152	0.000445	CcSEcCtD
Risedronate—Nausea—Glyburide—type 2 diabetes mellitus	0.000152	0.000445	CcSEcCtD
Risedronate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000152	0.000445	CcSEcCtD
Risedronate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000152	0.000445	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000152	0.000444	CcSEcCtD
Risedronate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000152	0.000443	CcSEcCtD
Risedronate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00015	0.00044	CcSEcCtD
Risedronate—Asthenia—Orlistat—type 2 diabetes mellitus	0.00015	0.000438	CcSEcCtD
Risedronate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000149	0.000437	CcSEcCtD
Risedronate—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000149	0.000437	CcSEcCtD
Risedronate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000148	0.000434	CcSEcCtD
Risedronate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000148	0.000432	CcSEcCtD
Risedronate—Fatigue—Losartan—type 2 diabetes mellitus	0.000147	0.000431	CcSEcCtD
Risedronate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000146	0.000428	CcSEcCtD
Risedronate—Constipation—Losartan—type 2 diabetes mellitus	0.000146	0.000427	CcSEcCtD
Risedronate—Pain—Losartan—type 2 diabetes mellitus	0.000146	0.000427	CcSEcCtD
Risedronate—Rash—Gliclazide—type 2 diabetes mellitus	0.000145	0.000424	CcSEcCtD
Risedronate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000145	0.000424	CcSEcCtD
Risedronate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000144	0.000423	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	0.000144	0.00116	CbGpPWpGaD
Risedronate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000144	0.000422	CcSEcCtD
Risedronate—Shock—Ramipril—type 2 diabetes mellitus	0.000144	0.000421	CcSEcCtD
Risedronate—Headache—Gliclazide—type 2 diabetes mellitus	0.000144	0.000421	CcSEcCtD
Risedronate—FDPS—Metabolism—CPT1A—type 2 diabetes mellitus	0.000144	0.00115	CbGpPWpGaD
Risedronate—FDPS—Metabolism—MTR—type 2 diabetes mellitus	0.000144	0.00115	CbGpPWpGaD
Risedronate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000144	0.00042	CcSEcCtD
Risedronate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000143	0.00042	CcSEcCtD
Risedronate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000143	0.00042	CcSEcCtD
Risedronate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000143	0.000418	CcSEcCtD
Risedronate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000142	0.000416	CcSEcCtD
Risedronate—FDPS—Metabolism—NAMPT—type 2 diabetes mellitus	0.000141	0.00113	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.00014	0.00112	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LIPC—type 2 diabetes mellitus	0.00014	0.00112	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HBA1—type 2 diabetes mellitus	0.00014	0.00112	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GCK—type 2 diabetes mellitus	0.00014	0.00112	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—type 2 diabetes mellitus	0.00014	0.00112	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00014	0.000409	CcSEcCtD
Risedronate—Dizziness—Valsartan—type 2 diabetes mellitus	0.00014	0.000409	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000139	0.00112	CbGpPWpGaD
Risedronate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000138	0.000404	CcSEcCtD
Risedronate—Asthenia—Metformin—type 2 diabetes mellitus	0.000138	0.000404	CcSEcCtD
Risedronate—FDPS—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000137	0.0011	CbGpPWpGaD
Risedronate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000137	0.000399	CcSEcCtD
Risedronate—Pruritus—Metformin—type 2 diabetes mellitus	0.000136	0.000398	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—LEP—type 2 diabetes mellitus	0.000136	0.00109	CbGpPWpGaD
Risedronate—Urticaria—Losartan—type 2 diabetes mellitus	0.000136	0.000397	CcSEcCtD
Risedronate—FDPS—Metabolism—CETP—type 2 diabetes mellitus	0.000135	0.00108	CbGpPWpGaD
Risedronate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000135	0.000395	CcSEcCtD
Risedronate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000135	0.000395	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	0.000135	0.00108	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.000135	0.00108	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALB—type 2 diabetes mellitus	0.000135	0.00108	CbGpPWpGaD
Risedronate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000134	0.000393	CcSEcCtD
Risedronate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000134	0.000391	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—type 2 diabetes mellitus	0.000134	0.00107	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000133	0.00039	CcSEcCtD
Risedronate—Rash—Valsartan—type 2 diabetes mellitus	0.000133	0.000389	CcSEcCtD
Risedronate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000133	0.000389	CcSEcCtD
Risedronate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000133	0.000388	CcSEcCtD
Risedronate—Insomnia—Ramipril—type 2 diabetes mellitus	0.000132	0.000387	CcSEcCtD
Risedronate—Headache—Valsartan—type 2 diabetes mellitus	0.000132	0.000387	CcSEcCtD
Risedronate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000132	0.000385	CcSEcCtD
Risedronate—Rash—Orlistat—type 2 diabetes mellitus	0.000132	0.000385	CcSEcCtD
Risedronate—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000131	0.000385	CcSEcCtD
Risedronate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000131	0.000385	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.000131	0.00105	CbGpPWpGaD
Risedronate—Headache—Orlistat—type 2 diabetes mellitus	0.000131	0.000382	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000131	0.00105	CbGpPWpGaD
Risedronate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000131	0.000382	CcSEcCtD
Risedronate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00013	0.000381	CcSEcCtD
Risedronate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000129	0.000377	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—BCL2—type 2 diabetes mellitus	0.000129	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	0.000129	0.00103	CbGpPWpGaD
Risedronate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000128	0.000376	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—ICAM1—type 2 diabetes mellitus	0.000128	0.00102	CbGpPWpGaD
Risedronate—Dizziness—Metformin—type 2 diabetes mellitus	0.000127	0.000372	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—NOS2—type 2 diabetes mellitus	0.000127	0.00101	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000126	0.00037	CcSEcCtD
Risedronate—Fatigue—Ramipril—type 2 diabetes mellitus	0.000126	0.000369	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000126	0.00101	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PSMD6—type 2 diabetes mellitus	0.000126	0.00101	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SNAP25—type 2 diabetes mellitus	0.000126	0.00101	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SREBF1—type 2 diabetes mellitus	0.000126	0.00101	CbGpPWpGaD
Risedronate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000126	0.000368	CcSEcCtD
Risedronate—Nausea—Valsartan—type 2 diabetes mellitus	0.000125	0.000367	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.000125	0.001	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.000125	0.001	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.000125	0.001	CbGpPWpGaD
Risedronate—Constipation—Ramipril—type 2 diabetes mellitus	0.000125	0.000366	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—type 2 diabetes mellitus	0.000125	0.000999	CbGpPWpGaD
Risedronate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000124	0.000363	CcSEcCtD
Risedronate—Nausea—Orlistat—type 2 diabetes mellitus	0.000124	0.000363	CcSEcCtD
Risedronate—FDPS—Metabolism—CTGF—type 2 diabetes mellitus	0.000124	0.000988	CbGpPWpGaD
Risedronate—Asthenia—Losartan—type 2 diabetes mellitus	0.000123	0.000358	CcSEcCtD
Risedronate—FDPS—Metabolism—HMGCR—type 2 diabetes mellitus	0.000122	0.000979	CbGpPWpGaD
Risedronate—Vomiting—Metformin—type 2 diabetes mellitus	0.000122	0.000358	CcSEcCtD
Risedronate—Rash—Metformin—type 2 diabetes mellitus	0.000121	0.000355	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	0.000121	0.000969	CbGpPWpGaD
Risedronate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000121	0.000354	CcSEcCtD
Risedronate—Pruritus—Losartan—type 2 diabetes mellitus	0.000121	0.000353	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000121	0.000966	CbGpPWpGaD
Risedronate—Headache—Metformin—type 2 diabetes mellitus	0.00012	0.000352	CcSEcCtD
Risedronate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00012	0.000351	CcSEcCtD
Risedronate—FDPS—Metabolism—ADRA2A—type 2 diabetes mellitus	0.00012	0.000958	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00012	0.00035	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000118	0.000947	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000117	0.000937	CbGpPWpGaD
Risedronate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000117	0.000342	CcSEcCtD
Risedronate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000116	0.00034	CcSEcCtD
Risedronate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000116	0.000339	CcSEcCtD
Risedronate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000116	0.000339	CcSEcCtD
Risedronate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000115	0.000338	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000115	0.000921	CbGpPWpGaD
Risedronate—Rash—Irbesartan—type 2 diabetes mellitus	0.000114	0.000335	CcSEcCtD
Risedronate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000114	0.000334	CcSEcCtD
Risedronate—Nausea—Metformin—type 2 diabetes mellitus	0.000114	0.000334	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CCL2—type 2 diabetes mellitus	0.000114	0.000914	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000114	0.00091	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000114	0.00091	CbGpPWpGaD
Risedronate—Headache—Irbesartan—type 2 diabetes mellitus	0.000114	0.000333	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.000114	0.000909	CbGpPWpGaD
Risedronate—Dizziness—Losartan—type 2 diabetes mellitus	0.000113	0.00033	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.000112	0.000894	CbGpPWpGaD
Risedronate—PTGS2—Disease—VPS26A—type 2 diabetes mellitus	0.000111	0.00089	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000111	0.000888	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.00011	0.000883	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GCG—type 2 diabetes mellitus	0.000109	0.000873	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000109	0.000873	CbGpPWpGaD
Risedronate—Vomiting—Losartan—type 2 diabetes mellitus	0.000109	0.000318	CcSEcCtD
Risedronate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000108	0.000316	CcSEcCtD
Risedronate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000108	0.000315	CcSEcCtD
Risedronate—Rash—Losartan—type 2 diabetes mellitus	0.000108	0.000315	CcSEcCtD
Risedronate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000108	0.000315	CcSEcCtD
Risedronate—Headache—Losartan—type 2 diabetes mellitus	0.000107	0.000313	CcSEcCtD
Risedronate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000105	0.000307	CcSEcCtD
Risedronate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000104	0.000303	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	0.000102	0.000817	CbGpPWpGaD
Risedronate—Nausea—Losartan—type 2 diabetes mellitus	0.000101	0.000297	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000101	0.000806	CbGpPWpGaD
Risedronate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.0001	0.000293	CcSEcCtD
Risedronate—Dizziness—Ramipril—type 2 diabetes mellitus	9.68e-05	0.000283	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	9.5e-05	0.00076	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	9.5e-05	0.00076	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.4e-05	0.000752	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GNB3—type 2 diabetes mellitus	9.4e-05	0.000752	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HMOX1—type 2 diabetes mellitus	9.36e-05	0.000749	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—BHMT—type 2 diabetes mellitus	9.32e-05	0.000745	CbGpPWpGaD
Risedronate—Vomiting—Ramipril—type 2 diabetes mellitus	9.31e-05	0.000272	CcSEcCtD
Risedronate—FDPS—Metabolism—CAT—type 2 diabetes mellitus	9.24e-05	0.000739	CbGpPWpGaD
Risedronate—Rash—Ramipril—type 2 diabetes mellitus	9.23e-05	0.00027	CcSEcCtD
Risedronate—Dermatitis—Ramipril—type 2 diabetes mellitus	9.22e-05	0.00027	CcSEcCtD
Risedronate—Headache—Ramipril—type 2 diabetes mellitus	9.17e-05	0.000268	CcSEcCtD
Risedronate—FDPS—Metabolism—APOB—type 2 diabetes mellitus	8.97e-05	0.000717	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTM1—type 2 diabetes mellitus	8.72e-05	0.000698	CbGpPWpGaD
Risedronate—Nausea—Ramipril—type 2 diabetes mellitus	8.7e-05	0.000254	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CASP3—type 2 diabetes mellitus	8.64e-05	0.000691	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LPL—type 2 diabetes mellitus	8.56e-05	0.000685	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ADCY5—type 2 diabetes mellitus	8.38e-05	0.00067	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GPX1—type 2 diabetes mellitus	8.35e-05	0.000668	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MMP9—type 2 diabetes mellitus	8.17e-05	0.000653	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AANAT—type 2 diabetes mellitus	8.14e-05	0.000651	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTGDS—type 2 diabetes mellitus	8.14e-05	0.000651	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CD36—type 2 diabetes mellitus	8.13e-05	0.000651	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC5A4—type 2 diabetes mellitus	8.12e-05	0.000649	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPP2CA—type 2 diabetes mellitus	8.03e-05	0.000643	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	7.95e-05	0.000636	CbGpPWpGaD
Risedronate—PTGS2—Disease—ENPP1—type 2 diabetes mellitus	7.84e-05	0.000627	CbGpPWpGaD
Risedronate—PTGS2—Disease—G6PC—type 2 diabetes mellitus	7.84e-05	0.000627	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPP1R3C—type 2 diabetes mellitus	7.84e-05	0.000627	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	7.77e-05	0.000621	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	7.74e-05	0.000619	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPD2—type 2 diabetes mellitus	7.72e-05	0.000618	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CDO1—type 2 diabetes mellitus	7.72e-05	0.000618	CbGpPWpGaD
Risedronate—FDPS—Metabolism—MTHFR—type 2 diabetes mellitus	7.71e-05	0.000617	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	7.64e-05	0.000611	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARA—type 2 diabetes mellitus	7.56e-05	0.000605	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	7.54e-05	0.000604	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	7.5e-05	0.0006	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AK1—type 2 diabetes mellitus	7.36e-05	0.000589	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AGT—type 2 diabetes mellitus	7.32e-05	0.000586	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	7.28e-05	0.000582	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CALM1—type 2 diabetes mellitus	7.2e-05	0.000576	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOE—type 2 diabetes mellitus	7.18e-05	0.000574	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOA1—type 2 diabetes mellitus	7.09e-05	0.000567	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC5A4—type 2 diabetes mellitus	6.8e-05	0.000544	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MAT1A—type 2 diabetes mellitus	6.8e-05	0.000544	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	6.77e-05	0.000541	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TGFB1—type 2 diabetes mellitus	6.73e-05	0.000538	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	6.67e-05	0.000533	CbGpPWpGaD
Risedronate—PTGS2—Disease—ACACA—type 2 diabetes mellitus	6.66e-05	0.000533	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	6.64e-05	0.000531	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—EGFR—type 2 diabetes mellitus	6.6e-05	0.000528	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	6.58e-05	0.000527	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—G6PC—type 2 diabetes mellitus	6.56e-05	0.000525	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HBA2—type 2 diabetes mellitus	6.56e-05	0.000525	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ND1—type 2 diabetes mellitus	6.56e-05	0.000525	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPP1R3C—type 2 diabetes mellitus	6.56e-05	0.000525	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ENPP1—type 2 diabetes mellitus	6.56e-05	0.000525	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	6.41e-05	0.000513	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GCGR—type 2 diabetes mellitus	6.36e-05	0.000509	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TNF—type 2 diabetes mellitus	6.28e-05	0.000503	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARG—type 2 diabetes mellitus	6.25e-05	0.0005	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC5A2—type 2 diabetes mellitus	6.15e-05	0.000492	CbGpPWpGaD
Risedronate—FDPS—Metabolism—INS—type 2 diabetes mellitus	6.13e-05	0.00049	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	6.12e-05	0.00049	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—OXCT1—type 2 diabetes mellitus	6e-05	0.00048	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYTB—type 2 diabetes mellitus	6e-05	0.00048	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	5.88e-05	0.00047	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SRD5A1—type 2 diabetes mellitus	5.85e-05	0.000468	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALB—type 2 diabetes mellitus	5.62e-05	0.00045	CbGpPWpGaD
Risedronate—PTGS2—Disease—PCK1—type 2 diabetes mellitus	5.58e-05	0.000447	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—STAR—type 2 diabetes mellitus	5.58e-05	0.000446	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ACACA—type 2 diabetes mellitus	5.58e-05	0.000446	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSD17B3—type 2 diabetes mellitus	5.58e-05	0.000446	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	5.5e-05	0.00044	CbGpPWpGaD
Risedronate—PTGS2—Disease—TLE4—type 2 diabetes mellitus	5.43e-05	0.000435	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3R1—type 2 diabetes mellitus	5.38e-05	0.00043	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NOS3—type 2 diabetes mellitus	5.38e-05	0.00043	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	5.35e-05	0.000428	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	5.35e-05	0.000428	CbGpPWpGaD
Risedronate—PTGS2—Disease—HK1—type 2 diabetes mellitus	5.23e-05	0.000418	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	5.15e-05	0.000412	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	5.15e-05	0.000412	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	5.12e-05	0.00041	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	5.07e-05	0.000406	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	5.06e-05	0.000405	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	5.06e-05	0.000405	CbGpPWpGaD
Risedronate—PTGS2—Disease—GCKR—type 2 diabetes mellitus	5.05e-05	0.000404	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	4.99e-05	0.000399	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	4.97e-05	0.000398	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	4.97e-05	0.000398	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	4.97e-05	0.000398	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—type 2 diabetes mellitus	4.92e-05	0.000393	CbGpPWpGaD
Risedronate—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	4.84e-05	0.000387	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.82e-05	0.000386	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	4.68e-05	0.000374	CbGpPWpGaD
Risedronate—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	4.62e-05	0.00037	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	4.6e-05	0.000368	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.58e-05	0.000366	CbGpPWpGaD
Risedronate—PTGS2—Disease—RBP4—type 2 diabetes mellitus	4.5e-05	0.00036	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	4.49e-05	0.000359	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	4.49e-05	0.000359	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	4.38e-05	0.00035	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	4.37e-05	0.00035	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	4.28e-05	0.000342	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	4.23e-05	0.000338	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	4.23e-05	0.000338	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	4.23e-05	0.000338	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	4.23e-05	0.000338	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	4.2e-05	0.000336	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTR—type 2 diabetes mellitus	4.12e-05	0.000329	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	4.07e-05	0.000325	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	4.06e-05	0.000324	CbGpPWpGaD
Risedronate—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	4.04e-05	0.000323	CbGpPWpGaD
Risedronate—PTGS2—Disease—GCK—type 2 diabetes mellitus	4.01e-05	0.000321	CbGpPWpGaD
Risedronate—PTGS2—Disease—IAPP—type 2 diabetes mellitus	3.99e-05	0.000319	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.94e-05	0.000315	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	3.92e-05	0.000313	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.86e-05	0.000309	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.82e-05	0.000305	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	3.77e-05	0.000302	CbGpPWpGaD
Risedronate—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	3.67e-05	0.000294	CbGpPWpGaD
Risedronate—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	3.6e-05	0.000288	CbGpPWpGaD
Risedronate—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	3.6e-05	0.000288	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.52e-05	0.000282	CbGpPWpGaD
Risedronate—PTGS2—Disease—CYBA—type 2 diabetes mellitus	3.49e-05	0.000279	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	3.45e-05	0.000276	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	3.45e-05	0.000276	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	3.38e-05	0.00027	CbGpPWpGaD
Risedronate—PTGS2—Disease—CALCA—type 2 diabetes mellitus	3.37e-05	0.00027	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.36e-05	0.000269	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	3.36e-05	0.000269	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	3.36e-05	0.000269	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	3.36e-05	0.000269	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.34e-05	0.000267	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.28e-05	0.000262	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	3.25e-05	0.00026	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	3.24e-05	0.000259	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS1—type 2 diabetes mellitus	3.21e-05	0.000257	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.18e-05	0.000255	CbGpPWpGaD
Risedronate—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	3.17e-05	0.000254	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	3.12e-05	0.00025	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.02e-05	0.000242	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	3.01e-05	0.000241	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	3.01e-05	0.000241	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	3.01e-05	0.000241	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	2.96e-05	0.000237	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	2.93e-05	0.000235	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.89e-05	0.000231	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.87e-05	0.00023	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.76e-05	0.000221	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	2.73e-05	0.000218	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.73e-05	0.000218	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	2.71e-05	0.000217	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.66e-05	0.000213	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	2.63e-05	0.00021	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.61e-05	0.000209	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	2.61e-05	0.000209	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOB—type 2 diabetes mellitus	2.56e-05	0.000205	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—type 2 diabetes mellitus	2.47e-05	0.000198	CbGpPWpGaD
Risedronate—PTGS2—Disease—LPL—type 2 diabetes mellitus	2.45e-05	0.000196	CbGpPWpGaD
Risedronate—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	2.4e-05	0.000192	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	2.3e-05	0.000184	CbGpPWpGaD
Risedronate—PTGS2—Disease—CCR5—type 2 diabetes mellitus	2.26e-05	0.00018	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	2.25e-05	0.00018	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.25e-05	0.00018	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	2.24e-05	0.000179	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	2.21e-05	0.000177	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	2.2e-05	0.000176	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	2.15e-05	0.000172	CbGpPWpGaD
Risedronate—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	2.1e-05	0.000168	CbGpPWpGaD
Risedronate—PTGS2—Disease—IRS2—type 2 diabetes mellitus	2.1e-05	0.000168	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	2.09e-05	0.000167	CbGpPWpGaD
Risedronate—PTGS2—Disease—CALM1—type 2 diabetes mellitus	2.06e-05	0.000165	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOE—type 2 diabetes mellitus	2.05e-05	0.000164	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	2.05e-05	0.000164	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOA1—type 2 diabetes mellitus	2.03e-05	0.000162	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	2.01e-05	0.000161	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	2e-05	0.00016	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	1.95e-05	0.000156	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.92e-05	0.000154	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS2—type 2 diabetes mellitus	1.91e-05	0.000153	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	1.85e-05	0.000148	CbGpPWpGaD
Risedronate—PTGS2—Disease—IRS1—type 2 diabetes mellitus	1.83e-05	0.000146	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	1.81e-05	0.000145	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	1.75e-05	0.00014	CbGpPWpGaD
Risedronate—PTGS2—Disease—INS—type 2 diabetes mellitus	1.75e-05	0.00014	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	1.72e-05	0.000138	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	1.72e-05	0.000137	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	1.7e-05	0.000136	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT2—type 2 diabetes mellitus	1.69e-05	0.000136	CbGpPWpGaD
Risedronate—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	1.61e-05	0.000129	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	1.54e-05	0.000123	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS3—type 2 diabetes mellitus	1.54e-05	0.000123	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	1.5e-05	0.00012	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—INS—type 2 diabetes mellitus	1.47e-05	0.000117	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	1.35e-05	0.000108	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	1.29e-05	0.000103	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.29e-05	0.000103	CbGpPWpGaD
Risedronate—PTGS2—Disease—SRC—type 2 diabetes mellitus	1.14e-05	9.1e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	1.02e-05	8.13e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGFR—type 2 diabetes mellitus	9.97e-06	7.97e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—type 2 diabetes mellitus	7.66e-06	6.13e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—type 2 diabetes mellitus	7.07e-06	5.65e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	5.92e-06	4.73e-05	CbGpPWpGaD
